Abstract: Gynura medica leaf extract contains significant amounts of flavonols and phenolic acids and exhibits powerful hypoglycemic activity against diabetic rats in vivo. However, the hypoglycemic active constituents that exist in the plant have not been fully elaborated. The purpose of this study is to isolate and elaborate the hypoglycemic activity compounds against inhibition the yeast α-glucosidase in vitro. Seven phenolic compounds including five flavonols and two phenolic acids were isolated from the leaf of G. medica. Their structures were identified by the extensive NMR and mass spectral analyses as: kaempferol (1), quercetin (2), kaempferol-3-O-β-D-glucopyranoside (3), kaempferol-3-Orutinoside (4), rutin (5), chlorogenic acid (6) and 3,5-dicaffeoylquinic acid methyl ester (7). All of the compounds except 1 and 3 were isolated for the first time from G. medica. Compounds 1-7 were also assayed for their hypoglycemic activity against yeast α-glucosidase in vitro. All of the compounds except 1 and 6 showed good yeast α-glucosidase inhibitory activity with the IC 50 values of 1.67 mg/mL, 1.46 mg/mL, 0.38 mg/mL, 0.10 mg/mL and 0.53 mg/mL, respectively.
Introduction
Gynura medica is a recently newly found Gynura genus species belonging to the family of Compositae [1] . Previously, studies have demonstrated that the ethanol extract of G. medica showed good hypoglycemic activity in diabetic animal models [2, 3] . However, the active constituents were not elucidated. G. medica extract also showed good antioxidant activity and some flavonols and phenolic acids were isolated or identified by HPLC-MS [4, 5] . Many other plants of the genus of Gynura were found to inhibit the key enzymes relevant to type 2 diabetes (including α-glucosidase and α-amylase) and hypertension and show anti-diabetic and hypoglycemic activities [6] [7] [8] [9] [10] [11] [12] [13] [14] . The chemical constituents of the genus of Gynura included flavonoid, phenolic acid, cerebrosides, polysaccharide, alkaloids, terpenoids and sterols [15] [16] [17] [18] [19] . Phenolic acid, flavonoid and polysaccharide were the major hypoglycemic active components of Gynura genus.
Type 2 diabetes mellitus has become one of the world's leading chronic diseases. Postprandial hyperglycemia was recognized as the characteristic for the type 2 diabetes. Medicinal plants were used for screening the anti-diabetic agents through varieties models in vitro, including inhibition of α-glucosidase and α-amylase [20] [21] [22] , DPP-IV (dipeptidyl peptidase IV) [23] , PTP-1B (Protein Tyrosine Phosphatases 1B) [24] and activation of PPAR-γ (peroxisome proliferator-activated receptor γ) [25] . Moreover, α-glucosidase was frequently used to screening the therapeutic agents for the control of postprandial hyperglycemia from the natural medicinal plants and isolated compounds.
Although previous studies have already demonstrated the G. medica extract showed good hypoglycemic activity in vivo, little information is available concerning the chemical constituents relevant to the hypoglycemic activity of the plant. The purpose of this study is to isolate and elaborate the hypoglycemic activity compounds against inhibition the yeast α-glucosidase in vitro.
Results and Discussion
Ethanol extract of G. medica leaf was successively fractionated with chloroform, ethyl acetate (EA) and n-butanol. All of the three organic extracts were evaluated their activity of inhibition the yeast α-glucosidase in vitro. Ethyl acetate (EA) extract showed the best activity against yeast α-glucosidase (data not shown) and was further isolated to get the active constituents. Seven phenolic compounds ( Figure 1 ) including five flavonols and two phenolic acids were isolated and identified from the EA extract. Their structures were identified by the extensive NMR and mass spectral analyses. C-1', 1'' ), 113.7 (C-2', 2''), 145.4, 145.5 (C-3', 3''), 145.6, 145.9 (C-4', 4''), 115.0 (C-5', 5''), 121.5, 121.6 (C-6', 6''), 148.1, 148.2 (C-7', 7''), 113.6 (C-8', 8''), 167.0, 167.5 (C-9', 9''), 175.9 (COOCH 3 ), 53.7 (OCH 3 ). Therefore, compound 7 was identified as 3,5-dicaffeoylquinic acid methyl ester [29] .
Many Gynura species have recently been shown to exhibit hypoglycemic and carbohydrate enzyme inhibitory activities [11] [12] [13] [14] . The inhibition of yeast α-glucosidase activity of the extracts and pure phenolic compounds 1-7 were determined. The clinical anti-diabetic drug acarbose (8) was used as a reference ( Figure 2 and Table 1 ). All of the compounds showed yeast α-glucosidase inhibitory activity in a dose-dependent manner (Figure 2 ). Except compounds 1 and 6, others showed more than 50% inhibitory activity at 2.0 mg/mL concentrations. The IC 50 values were calculated (Table 1) . Compounds 4, 5 and 7 showed the best activity with the IC 50 values of 0.38 mg/mL, 0.10 mg/mL and 0.53 mg/mL, respectively. While the clinical anti-diabetic drug acarbose (8) showed moderate activity in vitro with the IC 50 values of 0.99 mg/mL, which was consistent with literature [29] . Compounds 2 and 3 also showed somewhat activity against yeast α-glucosidase. G. segetum and G. divaricata has recently been shown to exhibit two key enzymes relevant to type 2 diabetes including α-glucosidase and α-amylase [12] [13] [14] . It was reported that the flavonoids compounds maybe responsible for the α-glucosidase inhibitory activity. However, the active constituents were unknown [13] . An activity-guided phytochemical isolation method was used to study the active compounds in G. medica. Both crude extracts of ethyl acetate and n-buthanol were all showed α-glucosidase inhibitory activity compared with the positive durg acarbose (data not shown). However, the ethyl acetate extract showed better activity than n-buthanol extract. Therefore, the further isolation was conducted on the ethyl acetate extract. Seven phenolic compounds including five flavonols and two phenolic acids were isolated. Flavonol and its glycosides (2-5) and the dicaffeoylquinic acid methyl showed good activity, which was in good agreement with previous reports that many flavonoids from plants have been reported as α-glucosidase inhibitors [29, 30] .
Experimental Section

Plant Material
Gynura medica was obtained in July of 2010 from Huoshan districts, Anhui province, China. A voucher specimen (2010R01) was deposited at the pharmacy of The First College of Clinical Medical Science, China Three Gorges University. The G. medica leaves were dried at room temperature for three weeks and finely powdered in a knife mill. 
General Experimental Procedures
Extraction of G. medica Leaf
The weighed portion of the crude drug 2 kg was extracted twice with 80% ethanol (v/v) under reflux at 80 °C. The extract was evaporated to dryness in vacuo. The dry ethanol extract was successively fractionated with chloroform, ethyl acetate (EA) and n-butanol, respectively. The yields of those three organic extracts were 31.2 g, 56.5 g and 89.5 g, respectively. All of the extracts were evaluated according to their activity of inhibition the yeast α-glucosidase in vitro. The EA fraction was further chromatographed on a Silica gel column eluted with mixture of chloroform and methanol to afford six sub-fractions (Fr.A 1 -A 6 ). Fr.A 2 was further chromatographed on a Sephadex LH-20 column eluted with mixture of chloroform-methanol (1:1) to yield compound 1 (15 mg) and 2 (5.8 mg). Fr.A 3 and Fr.A 5 was further chromatographed on a Sephadex LH-20 column eluted with methanol and next on a RP-ODS column or semi-preparative HPLC to give compound 3 (11 mg), 4 (7.9 mg), 5 (8.2 mg), 6 (5.5 mg) and 7 (4.5 mg).
Yeast α-Glucosidase Inhibitory Assay
Yeast α-glucosidase inhibitory activity was determined as described in the literature [29] . Briefly, a mixture of 50 μL of different concentrations of the samples and 100 μL of 0.1 M phosphate buffer (pH 6.9) containing yeast α-glucosidase solution (1.0 U/mL) were incubated in 96 well plates at 25 °C for 10 min. After pre-incubation, 50 μL of 5 mM pNPG solution in 0.1 M phosphate buffer (pH 6.9) was added to each well at timed intervals. The reaction mixturses were incubated at 25 °C for 5 min.
Absorbance was recorded with a micro-plate reader (Multiskan MK3) at 405 nm before and after incubation with pNPG solution and compared to that of the control which had 50 μL buffer solutions instead of test samples. The yeast α-glucosidase inhibitory activity was expressed as inhibition % and was calculated as follows:
Where C 0 and C 5 were the OD values of control (buffer solutions instead of test samples) at 0 min and 5 min at 405 nm, respectively. S 0 and S 5 were the OD values of samples at 0 min and 5 min at 405 nm, respectively.
Conclusions
Seven phenolic compounds were isolated from the ethyl acetate extract of the leaf of G. medica. Their structures were identified as kaempferol (1), quercetin (2), kaempferol-3-O-β-D-glucopyranoside (3), kaempferol-3-O-rutinoside (4), rutin (5), chlorogenic acid (6) and 3,5-dicaffeoylquinic acid methyl ester (7) . All of the compounds except 1 and 3 were isolated from G. medica for the first time. All of the compounds except 1 and 6 were showed good yeast α-glucosidase inhibitory activity. Compounds 4, 5 and 7 showed promising activity with the IC 50 values of 0.38 mg/mL, 0.10 mg/mL and 0.53 mg/mL, respectively.
